The Anal Fissure Treatment Market is estimated to be valued at US$ 1,039.3 Mn in 2023 and is expected to exhibit a CAGR of 5.3% over the forecast period 2023 to 2030, as highlighted in a new report published by Coherent Market Insights.

Market Overview:

Anal fissure is a small tear or cut near the anal opening. It causes tearing or pain during bowel movements. Common treatments include topical medications and surgery. Topical medications like nitroglycerin help relax the internal anal sphincter and calcium channel blockers aid healing. Surgical treatment is usually reserved for long-standing cases. It aims to relax the sphincter and promote healing. Such treatment options help relieve symptoms and promote healing.

Market key trends:

Increasing prevalence of anal fissures is a major driver for the market. Factors such as constipation, diarrhea, obesity, and childbirth increase anal fissure risk. Around 11% women develop an anal fissure during vaginal childbirth due to tearing. People who frequently strain or pass hard stool are also at higher risk. Chronic constipation results in pressure damage to the anal canal tissues over time. This has led to rising anal fissure diagnosis rates. Estimates show around 31.9% people in North America and 31.4% in Europe suffer from constipation. This is expected to significantly impact market demand over the forecast period. Further, growing awareness about treatment and management of anal fissures is encouraging more patients to seek medical help rather than ignoring the problem.

Porter’s Analysis

Threat of new entrants: The Anal Fissure Treatment market has moderate threat of new entrants due to high capital requirements of developing drugs and treatments. New companies need to invest heavily in R&D to develop innovative products.

Bargaining power of buyers: Buyers have moderate bargaining power due to availability of alternative treatment options for anal fissures. However, availability of branded drugs provide some bargaining power to pharmaceutical companies.

Bargaining power of suppliers: Suppliers have low bargaining power in the Anal Fissure Treatment market due to availability of substitute raw materials. Suppliers cannot influence prices much due to competition.

Threat of new substitutes: Threat of new substitutes is low as available treatment options are effective however new treatment delivery methods can be a substitute threat.

Competitive rivalry: The Anal Fissure Treatment market witnesses high competition due to presence of many global players offering generic and branded drugs.

SWOT Analysis

Strength: Availability of various branded and generic treatment options. Growing awareness about anal fissures and their management.

Weakness: Higher costs associated with branded drugs. Possible side effects of medications like headaches and nausea.

Opportunity: Emergence of new treatment delivery methods. Untapped growth potential in developing regions.

Threats: Patent expiries of major drugs. Entry of generic competition eroding sales potential of existing players.

Key Takeaways

The Global Anal Fissure Treatment Market Size is expected to witness high growth, exhibiting CAGR of 5.3% over the forecast period, due to increasing incidence of anal fissures from conditions like constipation and childbirth. As per estimates, the global Anal Fissure Treatment market size for 2023 is US$ 1,039.3 Mn. Geographically, North America is expected to dominate the global Anal Fissure Treatment market owing to rising awareness and availability of advanced treatment options in countries like the US and Canada. However, Asia Pacific region is expected to witness fastest growth during the forecast period due to increasing healthcare expenditure and emergence of regional players.

Key players operating in the Anal Fissure Treatment market are Allergan, Novartis, Pfizer, Takeda Pharmaceutical Company, Cook Medical, Medtronic, Johnson & Johnson, AstraZeneca, GlaxoSmithKline, Sanofi, Merck, Abbott Laboratories, Bayer, Astellas Pharma, Aurobindo Pharma, Ferring Pharmaceuticals, Salix Pharmaceuticals, Eli Lilly, Bristol-Myers Squibb, Boehringer Ingelheim. Key players are focused on expanding their product portfolios through mergers and acquisitions to strengthen their market presence.

Get More Insights Here

https://www.newswirestats.com/anal-fissure-treatment-market-size-share-growth-outlook-2023/